1.44

7.69% -0.12

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $1.44, with a volume of 364.26K. It is down -7.69% in the last 24 hours and down -53.55% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$1.56

Open:

$1.6

24h Volume:

364.26K

Relative Volume:

0.07

Market Cap:

$5.31M

Revenue:

$513.90K

Net Income/Loss:

$-48.50M

P/E Ratio:

-0.0514

EPS:

-28.0101

Net Cash Flow:

$-28.99M

1W Performance:

-31.43%

1M Performance:

-53.55%

6M Performance:

-64.22%

1Y Performance:

-87.42%

1-Day Range:

$1.4101

$1.6412

1-Week Range:

$1.38

$2.17

52-Week Range:

$1.26

$13.54

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1079)

Industry

Medical Devices (140)

Phone

(801) 438-1036

Address

2401 S FOOTHILL DRIVE, SALT LAKE CITY

Employee

115

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	1.44	7.52M	513.90K	-48.50M	-28.99M	-28.01
ABT Abbott Laboratories	105.74	182.00B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	325.74	129.09B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	85.40	107.81B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	46.73	67.64B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.03	47.81B	6.30B	1.07B	1.09B	1.8406

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Jul 28, 2026

CODX Looks 3.8% Undervalued on GF Value™ as Market Prices in Cha - GuruFocus

Jul 28, 2026

Co-Diagnostics Joint Venture CoSara provides Ebola Test Kits for analytical studies - BioSpectrum Asia

Jul 28, 2026

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - Yahoo Finance

Jul 28, 2026

EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Benzinga

Jul 28, 2026

Jul 27, 2026

Co-Diagnostics, Inc. Announces Amendment to Equity Distribution Agreement with Maxim Group LLC – July 2026 SEC Filing Update – Minichart - Minichart

Jul 27, 2026

Co-DiagnosticsAmends Equity Distribution Agreement With Maxim Group For Common Stock SaleSEC Filing - TradingView

Jul 27, 2026

Co-Diagnostics Updates ATM With Maxim, Extends Share Standstill to Aug. 14, 2026 - TradingView

Jul 27, 2026